Trial intelligence / Profile preview

Tiotropium and Pulmonary Rehabilitation in COPD

NCT02172508Phase 4Terminated

Sponsor
Boehringer Ingelheim
Start
Jan 2004
Primary completion
Mar 2004
01

Overview

A Phase 4 trial of tiotropium in chronic obstructive pulmonary disease (COPD), sponsored by Boehringer Ingelheim. Started Jan 2004; status: terminated.

02

Drugs

tiotropium
03

Conditions

chronic obstructive pulmonary disease (COPD)

Beyond the preview

Go deeper on NCT02172508.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02172508.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call